Bright Lights, Big City: PHI’s debut on the OTCQB in New York

We’re excited about our very own ‘big apple’ moment — PHI’s shares are now trading on the OTCQB Market! This marks a thrilling chapter in our mission to connect with more global investors and extend our impact in regenerative medicine. Our new presence on the OTCQB, under the ticker symbol OTCQB:PHIXF, complements our Stockholm listing and opens the door to new growth opportunities.

From Stockholm to New York

PHI has received a warm welcome this week at the OTC Market Group’s headquarters in New York. A picture can’t fully capture our excitement and how this experience reinforces our commitment to our mission and our investors. This new venture into the US market is more than just a listing; it’s about making meaningful connections in this vibrant financial community and shaping our future to advance regenerative medicine with non-invasive live cell analysis (blog post).

Streaming now: CEO speaks on PHI’s exciting new chapter

Our CEO, Patrik Eschricht, joined Steve Darling from Proactive to introduce PHI and discuss how our technology is a game-changer for the future of regenerative medicine and AI. Watch their full conversation here, where Patrik shares insights into our journey and how the US-OTCQB listing plays a role in our growth strategy.

Tune in: OTCQB podcast episode with PHI

Patrik Eschricht joins the OTCQB Podcast (Season 8 Episode 23) to discuss how PHI distinguishes itself from competitors by working with the Wake Forest Institute of Regenerative Medicine, as well as how the company has taken action on the plans for the future. [added August 22, 2024]

Investor FAQ update to include your OTCQB questions

We’re updating our Investor FAQ to include your questions about this new chapter. Do you have any questions about our OTCQB dual-listing? Please send us your queries and help shape our FAQ update.


We’re thankful for the enthusiasm and support from our global community as we step into this new market. Let’s continue to shape the future of regenerative medicine together!